为探究灵芝孢子粉低聚糖对肠道菌群的调节功能,从破壁与未破壁灵芝孢子粉中提取制备2种灵芝孢子粉低聚糖,采用肠道菌群体外发酵模型,通过代谢产物中短链脂肪酸与产气的变化、低聚糖的利用情况以及菌群结构的变化,阐述其对肠道菌群的影响。结果发现,2种灵芝孢子粉低聚糖均能够被肠道菌群有效利用。与空白对照相比,添加低聚糖能显著促进主要短链脂肪酸(乙酸、丙酸、丁酸)的产出(P<0.05),且同时产生少量气体,促进肠道蠕动;此外,双歧杆菌和乳酸杆菌属等有益菌的相对丰度升高,而大肠杆菌属等有害菌的相对丰度有所降低。因此,所制备的灵芝孢子粉低聚糖对人体肠道菌群有显著的益生调节功能。
Unbroken/broken Ganoderma lucidum spore oligosaccharides (UGLS-O, BGLS-O) were extracted from sporoderm-unbroken and sporoderm-broken spores of Ganoderma lucidum, respectively. The effects of GLS oligosaccharides on gut microbiota were examined by using an in vitro fermentation model. The changes of short-chain fatty acids (SCFAs) and gas production in metabolites, the utilization of oligosaccharides, and the changes of bacterial phase were determined. The results showed that both UGLS-O and BGLS-O could be effectively utilized by gut microbiota. Compared with a blank control group, the groups added with GLS oligosaccharides significantly increased the yields of main SCFAs (e.g., acetic acid, propionic acid, butyric acid), and produced a small amount of gas to promote intestinal peristalsis. Furthermore, the relative abundances of beneficial bacteria (e.g., Bifidobacterium and Lactobacillus) were increased, while Escherichia coli was decreased. In conclusion, the prepared GLS oligosaccharides possessed significant effects on probiotic regulation of gut microbiota.
[1] BENZIE I F F, WACHTEL-GALOR S. Herbal medicine: biomolecular and clinical aspects[M]. CRC Press,2011.
[2] 唐柳,张志军,魏雪生,等.灵芝孢子粉药理作用研究进展[J].天津农业科学,2011,17(3):25-28.
[3] 王颖,魏佳韵,吴思佳,等.灵芝多糖结构特征及药理作用的研究进展[J].中药,2019,41(3):627-635.
[4] 张天柱,赵婉君,吴国梁,等.灵芝孢子粉抗抑郁作用机制研究[J].时珍国医国药,2015,26(1):16-18.
[5] BOH B. Ganoderma lucidum: a potential for biotechnological production of anti-cancer and immunomodulatory drugs[J]. Recent Patents on Anti-cancer Drug Discovery,2013,8(3):255-287.
[6] YUE G G L,FUNG K P,LEUNG P C,et al. Comparative studies on the immunomodulatory and antitumor activities of the different parts of fruiting body of Ganoderma lucidum and Ganoderma spores[J]. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives,2008,22(10):1 282-1 291.
[7] LI S,LI M,YUE H,et al. Structural elucidation of a pectic polysaccharide from Fructus Mori and its bioactivity on intestinal bacteria strains[J].Carbohydrate Polymers,2018,186:168-175.
[8] TURNBAUGH P J, HAMADY M, YATSUNENKO T, et al. A core gut microbiome in obese and lean twins[J]. Nature,2009,457(7 228):480-484.
[9] AZMI A F M N, MUSTAFA S, HASHIM D M, et al. Prebiotic activity of polysaccharides extracted from Gigantochloa levis (Buluh beting) shoots[J]. Molecules,2012,17(2):1 635-1 651.
[10] 王向红,吉爽爽,桑亚新,等.金丝小枣低聚糖的制备及其对双歧杆菌体外促生长的研究[J].中国食品学报.2012,12(9):28-33.
[11] 胡丽萍.灵芝孢子低聚糖的制备及其改性研究[D].广州:华南理工大学,2011.
[12] 渠婷.金钗石斛低聚糖的分离、结构鉴定及其功能性研究[D].无锡:江南大学,2017.
[13] DUBOIS M,GILLES K A,HAMILTON J K,et al. Colorimetric method for determination of sugars and related substances[J].Analytical Chemistry,1956,28(3):350-356.
[14] BRADFORD M M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding[J]. Analytical Biochemistry,1976,72(1-2):248-254.
[15] LI X, HU Q, JIANG S, et al. Flos Chrysanthemi Indici protects against hydroxyl-induced damages to DNA and MSCs via antioxidant mechanism[J]. Journal of Saudi Chemical Society,2015,19(4): 454-460.
[16] 吴琴琴.体外发酵模型检测食品营养组分对健康人与IBS-D病人肠道菌群的影响[D].金华:浙江师范大学,2018.
[17] FERIA-GERVASIO D, DENIS S, ALRIC M, et al. In vitro maintenance of a human proximal colon microbiota using the continuous fermentation system P-ECSIM[J]. Applied Microbiology and Biotechnology,2011,91(5):1 425-1 433.
[18] 郑志昌,陈映彤,郭娟娟,等.莲子低聚糖各单体体外益生效果研究[J].中国食品学报, 2019,19(7):56-63.
[19] 王增林,孙雪丽,刘桃桃,等.利用体外产气法研究饲粮中性洗涤纤维/淀粉对瘤胃甲烷产量的影响[J].动物营养学报,2019,31(7):3 251-3 259.
[20] MORRISON D J, PRESTON T. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism[J]. Gut Microbes,2016,7(3):189-200.
[21] 梁玉,赵鹏昊,尚佳萃,等.一月龄婴儿粪便菌群对五种非消化糖的体外发酵作用[J].食品工业科技,2019,40(21):72-77.
[22] OU J Z,YAO C K, ROTBART A, et al. Human intestinal gas measurement systems: in vitro fermentation and gas capsules[J]. Trends in Biotechnology,2015,33(4):208-213.
[23] CARBONERO F, BENEFIEL A C, GASKINS H R. Contributions of the microbial hydrogen economy to colonic homeostasis[J]. Nature Reviews Gastroenterology & Hepatology,2012,9(9):504.
[24] 张俊楠.体外发酵法研究铁皮石斛多糖对人肠道菌群的影响[D].厦门:厦门大学,2018.
[25] KOVATCHEVA-DATCHARY P, NILSSON A, AKRAMI R, et al. Dietary fiber-induced improvement in glucose metabolism is associated with increased abundance of Prevotella[J]. Cell Metabolism,2015,22(6):971-982.
[26] LA FATA G, RASTALL R, LACROIX C, et al. Recent development of prebiotic research-statement from an expert workshop[J]. Nutrients,2017,9(12):1376.
[27] HEALEY G, MURPHY R, BUTTS C, et al. Habitual dietary fibre intake influences gut microbiota response to an inulin-type fructan prebiotic: a randomised, double-blind, placebo-controlled, cross-over, human intervention study[J]. British Journal of Nutrition, 2018,119(2):176-189.
[28] YANG J, MARTÍNEZ I, WALTER J, et al. In vitro characterization of the impact of selected dietary fibers on fecal microbiota composition and short chain fatty acid production[J]. Anaerobe,2013,23:74-81.
